BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2770930)

  • 1. Flow cytometric analysis of primary cervical and vulvar carcinomas and their metastases.
    Siracký J; Kysela B; Siracká E
    Neoplasma; 1989; 36(4):437-45. PubMed ID: 2770930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar squamous carcinoma: prognostic role of DNA content.
    Mariani L; Conti L; Atlante G; Sciarretta F; Pozzi M; Vercillo M; Francavilla V; De Franceschi L; Rossi S; Sindico R; Atlante M; Gandolfo GM
    Gynecol Oncol; 1998 Nov; 71(2):159-64. PubMed ID: 9826454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of flow cytometric DNA analysis in patients with rectal cancer].
    Yamasaki S; Kumashiro R; Yoshitake H; Sano C; Maekawa T; Kido K; Tanaka K; Inutsuka S
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):775-9. PubMed ID: 8489285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
    Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
    Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of impulse cytophotometry in malignant tumors of the head and neck. A prognostic parameter?].
    Brauneis JW; Laskawi R; Schröder M; Göhde W
    HNO; 1989 Sep; 37(9):369-72. PubMed ID: 2808011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of DNA ploidy as a prognostic factor in uterine cervical cancer].
    Watanabe Y; Ikeda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1127-34. PubMed ID: 1453042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.
    Ballouk F; Ambros RA; Malfetano JH; Ross JS
    Mod Pathol; 1993 May; 6(3):371-5. PubMed ID: 8346186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
    Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.
    Corver WE; Ter Haar NT; Dreef EJ; Miranda NF; Prins FA; Jordanova ES; Cornelisse CJ; Fleuren GJ
    J Pathol; 2005 Jun; 206(2):233-41. PubMed ID: 15822070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rare metastasis of vulvar cancers].
    Schumacher A; Rohde E
    Zentralbl Gynakol; 1992; 114(7):379-81. PubMed ID: 1509837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry and cytomorphology in primary resectable breast cancer.
    Bedrossian CW; Raber M; Barlogie B
    Anal Quant Cytol; 1981 Jun; 3(2):112-6. PubMed ID: 6266303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of flow cytometric DNA analysis in metastatic lymph node of colorectal cancer].
    Ando Y; Tsuchiya A; Katagata N; Kanazawa M; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Abe R
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():41-6. PubMed ID: 8203929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.